Alfredo Pascual headshot
EMAIL: editorial@mjbizdaily.com
PHONE: 720.213.5992

Alfredo Pascual, International Analyst

Based in Germany, Alfredo specializes in international cannabis markets and regulations, drawing upon his extensive academic background in business and public policy. Pascual worked at MJBizDaily as international analyst from 2018 until early 2021.

France chooses companies to supply free medical cannabis for trial program

January 25, 2021 · Updated October 26, 2021

The French Agency for the Safety of Medicines and Health Products (ANSM) selected the companies that will supply France’s medical cannabis pilot program that’s intended to provide free products to patients enrolled in the trial. Cannabis companies from Australia, Canada, Israel and the United Kingdom – in partnership with French pharmaceutical distributors – will provide […]

Read More

French consultation on marijuana legalization passes 200,000 responses

January 25, 2021

A consultation on cannabis legalization in France that launched on Jan. 13 has already gathered 200,354 responses, Marijuana Business Daily has learned. The consultation is not expected to prompt a near-term legislative change, but a positive outcome could ease concerns for some politicians over potential reform ahead of the 2022 elections. “The numbers will be […]

Read More

Dutch recreational cannabis experiment advances after court appeal rejected

January 22, 2021 · Updated January 23, 2021

A Dutch judge rejected a request to annul the results of a lottery process used to select cultivators for the Netherlands’ recreational cannabis experiment. “This means the experiment will likely continue moving forward as planned,” Kaj Hollemans, a drug policy consultant based in the Netherlands, told Marijuana Business Daily. “It is now at the stage […]

Read More

Czech medical cannabis sales surge, but market remains small

January 21, 2021

The Czech market for medical cannabis flower quadrupled last year compared to 2019, according to data published by the State Agency for Medical Cannabis. However, the market remains very small. In 2020, roughly 68 kilograms (150 pounds) of medical cannabis flower was sold to patients in Czech pharmacies, compared with 17 kilograms the year before, […]

Read More

German entrepreneurs find revenue opportunities in private cannabis market

January 12, 2021 · Updated October 26, 2021

As public health-insurance payouts for medical cannabis in Germany stagnate, entrepreneurs are focusing instead on the private health-care sector, where medical consultations and marijuana is paid for directly by patients. Although Germany is often touted as an attractive market because statutory health insurers are expected to cover the cost of medical marijuana, opportunities in the […]

Read More

Denmark medical cannabis sales post a positive quarter thanks to Epidiolex

January 7, 2021

Sales of medical marijuana in Denmark posted healthy gains in the third quarter of 2020, coinciding with the launch of GW Pharmaceuticals’ cannabis drug Epidiolex. Overall sales of all medial cannabis products grew from about 13 million Danish Krones ($2 million) in the second quarter to almost 16 million Danish Krones in the third quarter, […]

Read More

Polish medical cannabis market growing rapidly but remains very small

January 5, 2021

The Polish medical cannabis market is growing rapidly, with imports through August 2020 more than doubling compared to 2019, Marijuana Business Daily has learned. This is believed to be the first time that accurate and updated import data about the Polish medical marijuana market has been publicly available. Access to aggregate market data measuring the […]

Read More

Survey: Majority in Germany still opposes adult-use cannabis legalization

December 24, 2020 · Updated September 15, 2021

A slim majority of eligible voters in Germany opposes legalizing recreational marijuana, according to a new poll. The results come from a survey conducted in December by Infratest dimap – one of the leading polling agencies and research institutes in Germany – for the advocacy group Hanfverband. The survey, along with a recent vote in […]

Read More

Australian medical cannabis available in German pharmacies for first time

December 23, 2020

Flower and extracts produced in Australia by two different companies are now available in the German medical cannabis market for the first time, Marijuana Business Daily has learned. The flower, grown by New South Wales-based Australian Natural Therapeutics Group (ANTG), was imported and batch-released by Cologne-based Cannamedical. Cannamedical exclusively sells it to German pharmacies under the […]

Read More

European cannabis producer raises $20 million

December 21, 2020

Emmac Life Sciences, a European vertically integrated cannabis producer, said it raised 15 million pounds ($20 million) via an issue of convertible loan notes. The Dec. 16 issue “saw strong support from existing shareholders, with Measure 8 Venture Partners, Emmac’s largest existing cash investor, leading the round with a significant investment,” according to a news […]

Read More

Colombian agency recommends allowing cannabis flower exports

December 21, 2020

The Colombian government may reconsider its ban on medical cannabis flower exports for commercial purposes. A recent letter by the Superintendency of Industry and Commerce (SIC) – a government agency that promotes fair business practices – to the Ministry of Health recommended the country modify current regulations and allow flower exports. This is the first […]

Read More